DHI vs MDGL · P/E 9.6, rev $34.25B vs rev $675.6M
DR Horton Inc (DHI) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the DHI and MDGL stock pages for the full models.
Not investment advice.